Study title:
Glatiramer acetate treatment in patients with childhood juvenile onset multiple sclerosis - Kornek B, Bernert G, Balassy C, et al. - 2003 (Neuropediatrics 2003; 34: 120-126)
Glatiramer acetate treatment in patients with childhood juvenile onset multiple sclerosis - Kornek B, Bernert G, Balassy C, et al. - 2003 (Neuropediatrics 2003; 34: 120-126)
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Nervous System Diseases [C10]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: GLATITRAMER |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
-
|
-
|